<!DOCTYPE html>
<html lang="en">
    <head>
    <title>Nazokat Isamova|INFO 2439|Helathcare</title>
<meta name="viewport" 
      content="width=device-width, initial-scale=1">	
<link rel="stylesheet" 
      href="http://code.jquery.com/mobile/1.4.5/jquery.mobile-1.4.5.min.css" />
<script type="text/javascript" 
        src="http://code.jquery.com/jquery-2.1.3.min.js">
</script>
<script type="text/javascript" 
        src="http://code.jquery.com/mobile/1.4.5/jquery.mobile-1.4.5.min.js">
</script>
</head>
    <body>
    <!-- Nazokat Isamova
    Applied Challange 2
    INFO_2439
    Brown
    10/08/2017
-->
<div data-role="page">
	<div data-role="header">
	<a href="trade.html" data-icon="back">Back</a>
		<h1>Healthcare Sector</h1>
	</div>
	<div class="ui-content">
	<!--CONTENT HERE-->
	<p>Healthcare Sector:<br>
	<!-- text adopted form Folio First--www.foliofirst.com--->
		Business realted to hospitals, biotech and variuos medical products. This sector consists of companies engaged in manufacturing medical equipment, supplies and pharmaceuticals, as well as operating healthcare facilities like hospitals and health services such as managed healthcare(HMOs). This field is experiencing rapid technological advances, helping to create more options through new cures and medical procedures that can dramatically improve the quality of life.</p>
<!-- BUTTONS HERE -->
<div data-role="tabs">
			<div data-role="navbar">
			<ul>
				<li><a href="#tab1">ABT</a></li>
				<li><a href="#tab2">ABBV</a></li>
				<li><a href="#tab3">AET</a></li>
			</ul>
			</div>
	
			
			<div id="tab1">
				<p> Compnay Profile:<br>
					<b>Abbott Laboratories(ABT)</b> engages in the discovery, development, manufacture and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, and Vascular Products. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories and alternate-care testing sites. The Vascular Products segment trades coronary, endovascular, structural heart, vessel closure and other medical device products. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.
				</p>
				<p> Market Capitalization:$95,437.14 million (Market data by Xignite and company information provided by Folio First: foliofirst.com</p>
			</div>

			<div id="tab2">
				<p>Company Profile:<br>
					<b>AbbVie, Inc.(ABBV)</b> is a research-based biopharmaceutical company. It engages in the discovery, development, manufacture and sale of a broad line of proprietary pharmaceutical products. The company focused on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C and human immunodeficiency virus; neurological disorders, such as Parkinson's disease; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis; as well as other serious health conditions. The company was founded on January 1, 2013 and is headquartered in North Chicago, IL.
				</p>
				<p> Market Capitalization:$149,652.51 million (Market data by Xignite and company information provided by Folio First: foliofirst.com</p>
			</div>

			<div id="tab3">
<p>Company Profile:<br>
	<b> Aetna, Inc.(AET)</b> engages in the provision of traditional, voluntary, and consumer-directed health insurance products and related services. It operates through the following segments: Health Care, Group Insurance, and Large Case Pensions. The Health Care segment consists of medical, pharmacy benefit management services, dental, behavioral health, and vision plans offered on insured and employer-funded basis. The Group Insurance segment includes group life insurance and group disability products. The Large Case Pensions segment manages retirement products for tax-qualified pension plans. The company was founded by Eliphalet Adams Bulkeley in 1853 and is headquartered in Hartford, CT.
</p>
<p> Market Capitalization:$55,763.10 million (Market data by Xignite and company information provided by Folio First: foliofirst.com</p>
</div>
</div>
<!-- SECOND ROW OF BUTTONS HERE -->
<div data-role="tabs">
			<div data-role="navbar">
			<ul>
				<li><a href="#tab4">AGN</a></li>
				<li><a href="#tab5">AMGN</a></li>
				<li><a href="#tab6">ANTM</a></li>
			</ul>
			</div>
<div id="tab4">
<p>Company Profile:<br>
	<b>Allergan Plc(AGN)</b>engages in the research, development, and manufacture of pharmaceutical products. It operates through the following segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded on in 1984 and is headquartered in Dublin, Ireland.
</p>
<p> Market Capitalization:$57,556.43 million (Market data by Xignite and company information provided by Folio First: foliofirst.com</p>
</div>
<div id="tab5">
<p>Company Profile:<br>
	<b>Amgen, Inc.(AMGN)</b>is a biotechnology medicines company, which discovers, develops, manufactures and markets medicines for grievous illnesses. The company focuses on human therapeutics and concentrates on innovating novel medicines based on advances in cellular and molecular biology. Its products include aranesp, blincyto, corlanor, enbrel, epogen, imlygic, kyprolis, neulasta, neupogen, nplate, parsab, prolia, repatha, sensipar, vectibix, and xgeva. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.
	</p>
	<p> Market Capitalization:$123,071.51 million (Market data by Xignite and company information provided by Folio First: foliofirst.com</p>
	</div>
<div id="tab6">
<p>Company Profile<br>
	<b>Anthem, Inc.(ANTM)</b>provides life, hospital and medical insurance plans. It offers a broad spectrum of network-based managed care health benefit plans to the large and small employer, individual, Medicaid, and Medicare markets. The company operates through three segments: Commercial & Specialty Business, Government Business and Other. The Commercial and Specialty Business segment includes local group, national accounts, and individual and specialty businesses. The Government Business segment includes medi care and medic aid businesses, national government services and services provided to the federal government in connection with federal employee program. The Other segment includes other businesses that do not meet the quantitative thresholds for an operating segment as defined by financial accounting standards board guidance, as well as corporate expenses not allocated to the other reportable segments. Anthem was founded on November 30, 2004 and is headquartered in Indianapolis, IN.
	</p>
	<p> Market Capitalization:$56,165.72 million (Market data by Xignite and company information provided by Folio First: foliofirst.com</p>
			</div>
			</div>
		
	<!-- THIRD ROW OF BUTTONS HERE -->
<div data-role="tabs">
			<div data-role="navbar">
			<ul>
				<li><a href="#tab7">BIIB</a></li>
				<li><a href="#tab8">BMY</a></li>
				<li><a href="#tab9">CELG</a></li>
			</ul>
			</div>
<div id="tab7">
<p>Company Profile:<br>
	<b>Biogen, Inc.(BIIB)</b> is a global biotechnology company, which focuses on discovering, developing, manufacturing and delivering therapies for neurological, autoimmune and hematologic disorders. Its products include AVONEX, PLEGRIDY, TECFIDERA, TYSABRI, and FAMPYRA for multiple sclerosis, ALPROLIX for hemophilia B and ELOCTATE for hemophilia A. The company also collaborates on the development and commercialization of RITUXAN for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia and other conditions and share profits and losses for GAZYVA which is approved for the treatment of chronic lymphocytic leukemia. Biogen was founded by Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA.
</p>
<p> Market Capitalization:$65,617.06 million (Market data by Xignite and company information provided by Folio First: foliofirst.com</p>
</div>
<div id="tab8">
<p>Company Profile:<br>
	<b>Bristol-Myers Squibb Co.(BMY)</b> operates as a biopharmaceutical company, which engages in the discovery, development, licensing, manufacturing, marketing, distribution, and sale of biopharmaceutical products. It includes chemically-synthesized drugs or small molecules and products produced from biological processes called biologics. The company was founded in August 1933 and is headquartered in New York, NY.
	</p>
	<p> Market Capitalization:$99,953.25 million (Market data by Xignite and company information provided by Folio First: foliofirst.com</p>
	</div>
<div id="tab9">
<p>Company Profile<br>
	<b>Celgene Corp.(CELG)</b> is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its targeting areas include intracellular signaling pathways, protein homeostasis and epigenetics in cancer and immune cells, immunomodulation in cancer and autoimmune diseases and therapeutic application of cell therapies. The company's products include Revlimid, Vidaza, Thalomid, Pomalyst/Imnovid, Abraxane, and Istodax. Celgene was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ.
	</p>
	<p> Market Capitalization:$78,977.61 million (Market data by Xignite and company information provided by Folio First: foliofirst.com</p>
			</div>
			</div>
	</div>
<!--FOOTER HERE-->		
<div data-role="footer">
<h4><a href="mailto:nisamova@mail.mccneb.edu">Nazokat Isamova &copy;</a> Fall 2017</h4>
</div>
		</div>
</body>
</html>

